痴呆症护理研究和心理社会因素
Julia L Waszak1, Gabriel Gach1, Carson Hovey1
1Montana College of Osteopathic Medicine, Billings, MT, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
ангиотензинII受体阻断剂 (ARBs) 在早期阿尔茨海默病 (AD) 中显示出潜在的神经保护性益处. 这些广泛使用的药物可能会减缓临床前阿尔茨海默病的病理变化,为其他疗法提供了具有成本效益的替代方案.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 老年学是一门学科.
背景情况:
- 在认知症状出现之前,人们对治疗临床前阿尔茨海默氏症 (AD) 的兴趣越来越大.
- 需要可访问,具有神经保护潜力的经济有效疗法.
- 抗胰岛素II受体抑制剂 (ARBs) 正在探索其抗炎和血管扩张作用,以减少粉样β (Ab) 斑块的形成.
研究的目的:
- 审查有关阿尔茨海默病 (AD) 中ARBs的现有临床试验数据.
- 评估ARB作为临床前AD治疗策略的潜力.
- 评论ARB作为可访问的治疗选择的可行性.
主要方法:
- 在包括PubMed,NIH临床试验,NEJM和JAMA在内的数据库中进行文献搜索.
- 使用的关键词:"阿尔茨海默病"",临床前"和"ARBs".
- 对认知正常的成年人和有症状的阿尔茨海默病患者的研究分析.
主要成果:
- 像SCOPE和ONTARGET/TRANSCEND这样的研究研究了ARB在认知正常的成年人中的神经保护作用.
- 像RADAR和CEDAR这样的试验在症状AD中探索了ARB.
- 在CEDAR研究中表明,德沙坦治疗减少了Ab积累.
结论:
- 单克隆抗体在阿尔茨海默病中表现出疾病修饰作用,并正在临床前阿尔茨海默病中进行测试.
- ARB可以提供额外的神经保护,并作为一个具有成本效益的,可访问的替代品.
- 未来通过生物标志物对临床前阿尔茨海默病的诊断可能使ARB早期干预能够减缓病理.
更多相关视频
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.3K
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
14.1K
相关概念视频
01:30Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
01:29Psychological and Sociocultural Causes of Schizophrenia
438
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
438
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:22Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
01:30Cognitive Development During Adulthood
740
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
740
01:29Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K